LFST Fundamental Analysis - LIFEIST WELLNESS INC

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to LFST. LFST was compared to 1 industry peers in the Distributors industry. No worries on liquidiy or solvency for LFST as it has an excellent financial health rating, but there are worries on the profitability. LFST has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

LFST had negative earnings in the past year.
In the past year LFST has reported a negative cash flow from operations.
In the past 5 years LFST always reported negative net income.
LFST had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

LFST's Return On Assets of -72.39% is amongst the best of the industry. LFST outperforms 100.00% of its industry peers.
LFST has a Return On Equity of -112.19%. This is amongst the best in the industry. LFST outperforms 100.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-72.39%
ROE	-112.19%
ROIC	N/A

ROA(3y)-69.42%

ROA(5y)-67.58%

ROE(3y)-186.48%

ROE(5y)-148.09%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 71.38%, LFST belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of LFST has grown nicely.
LFST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	71.38%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y97.09%

GM growth 5Y33.77%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

LFST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFST has more shares outstanding
The number of shares outstanding for LFST has been reduced compared to 5 years ago.
LFST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

LFST has an Altman-Z score of -116.88. This is a bad value and indicates that LFST is not financially healthy and even has some risk of bankruptcy.
LFST has a Altman-Z score of -116.88. This is amongst the best in the industry. LFST outperforms 100.00% of its industry peers.
LFST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-116.88

ROIC/WACCN/A

WACC8.61%

2.3 Liquidity

A Current Ratio of 2.13 indicates that LFST has no problem at all paying its short term obligations.
The Current ratio of LFST (2.13) is better than 100.00% of its industry peers.
LFST has a Quick Ratio of 1.74. This is a normal value and indicates that LFST is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.74, LFST belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.13
Quick Ratio	1.74

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

LFST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.98%, which is quite impressive.
LFST shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -56.86%.
LFST shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -48.56% yearly.

EPS 1Y (TTM)92.98%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-117.67%

Revenue 1Y (TTM)-56.86%

Revenue growth 3Y-69.69%

Revenue growth 5Y-48.56%

Sales Q2Q%-98.41%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

LFST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

LFST does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

LIFEIST WELLNESS INC

TSX-V:LFST (1/16/2026, 7:00:00 PM)

0.035

0 (-12.5%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustryDistributors

Earnings (Last)10-28 2025-10-28

Earnings (Next)03-30 2026-03-30

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners5.8%

Ins Owner ChangeN/A

Market Cap1.33M

Revenue(TTM)588.80K

Net Income(TTM)-1.45M

Analysts80

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.25
P/FCF	N/A
P/OCF	N/A
P/B	1.03
P/tB	1.13
EV/EBITDA	N/A

EPS(TTM)-0.04

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.08

FCFYN/A

OCF(TTM)-0.08

OCFYN/A

SpS0.02

BVpS0.03

TBVpS0.03

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-72.39%
ROE	-112.19%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	71.38%
FCFM	N/A

ROA(3y)-69.42%

ROA(5y)-67.58%

ROE(3y)-186.48%

ROE(5y)-148.09%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y97.09%

GM growth 5Y33.77%

F-Score4

Asset Turnover0.29

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.13
Quick Ratio	1.74
Altman-Z	-116.88

F-Score4

WACC8.61%

ROIC/WACCN/A

Cap/Depr(3y)27.07%

Cap/Depr(5y)51.27%

Cap/Sales(3y)1.52%

Cap/Sales(5y)4%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)92.98%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-117.67%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-56.86%

Revenue growth 3Y-69.69%

Revenue growth 5Y-48.56%

Sales Q2Q%-98.41%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y31.8%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y7.02%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-4.37%

OCF growth 3YN/A

OCF growth 5YN/A

LIFEIST WELLNESS INC / LFST.CA FAQ

What is the fundamental rating for LFST stock?

ChartMill assigns a fundamental rating of 3 / 10 to LFST.CA.

What is the valuation status for LFST stock?

ChartMill assigns a valuation rating of 0 / 10 to LIFEIST WELLNESS INC (LFST.CA). This can be considered as Overvalued.

What is the profitability of LFST stock?

LIFEIST WELLNESS INC (LFST.CA) has a profitability rating of 3 / 10.

LIFEIST WELLNESS INC (LFST.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

LIFEIST WELLNESS INC / LFST.CA FAQ

What is the fundamental rating for LFST stock?

What is the valuation status for LFST stock?

What is the profitability of LFST stock?